Sort by 'shares'
Enhancing Diversity in Cancer Clinical Trials
For decades, there has been an alarming lack of diversity in cancer clinical trials. Why does this happen, what can we do about it and how can we increase minority representation in these potentially life-saving trials are some of the…
Bridging the Gap in Multiple Myeloma Survival
What is the gap in myeloma survival? Currently the National Cancer Institute reports a life expectancy of just over five years, whereas, myeloma specialists at myeloma centers of excellence have reported a life expectancy of over ten years for myeloma…
Understanding Lecithin Cholesterol Acyltransferase (LCAT) Deficiency Disorders
Lecithin cholesterol acyltransferase (LCAT) deficiency is a genetic disorder that affects the body's ability to process cholesterol. It is characterized by cloudiness of the clear front surface of the eye (corneal opacities), a shortage of red blood cells (hemolytic anemia),…
Multiple Myeloma: An Insight into Early Intervention and Personalized Therapies
Myeloma patients are definitely living longer. A decade ago the median survival was 3 to 4 years, while now it is in the range of 8 to 10 years. With all the new drugs and treatments that have been approved,…
Beating Leukemia with Groundbreaking CAR-T Cell Therapy
Dr. Stephan A. Grupp made history when he treated the first child with CAR T cell therapy, Emily Whitehead, who is now more than five years cancer-free. In CAR-T cell therapy, a patient's own genetically altered immune cells fight cancer.…